...
首页> 外文期刊>Heart >Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction
【24h】

Induction of ventricular fibrillation predicts sudden death in patients treated with amiodarone because of ventricular tachyarrhythmias after a myocardial infarction

机译:诱发心室纤颤可预测胺碘酮治疗的患者因心肌梗死后室性快速性心律失常而猝死

获取原文
获取原文并翻译 | 示例
           

摘要

Objective—To examine the value of programmed electrical stimulation of the heart in predicting sudden death in patients receiving amiodarone to treat ventricular tachyarrhythmias after myocardial infarction. Design—Consecutive patients; retrospective study. Setting—Referral centre for cardiology, academic hospital. Patients—106 patients with ventricular tachycardia (n = 77) or ventricular fibrillation (n = 29) late after myocardial infarction. Interventions—Programmed electrical stimulation was performed while on amiodarone treatment for at least one month. Measurements and main results—In 80/106 patients either ventricular fibrillation (n = 15) or sustained monomorphic ventricular tachycardia (n = 65) was induced. After a mean follow up of 50 (SD 40) months (1-144), 11 patients died suddenly and two used their implantable car-dioverter defibrillator. By multivariate analysis two predictors for sudden death were found: (1) inducibility of ventricular fibrillation under amiodarone treatment (P 0.001), and (2) a left ventricular ejection fraction of < 40% (P < 0.05). The survival rate at one, two, three, and five years was 70%, 62%, 62%, and 40% respectively for patients in whom ventricular fibrillation was induced, and 98%, 96%, 94%, 94% for patients with induced sustained monomorphic ventricular tachycardia. Where there was no sustained arrhythmia, five year survival was 100%. Conclusions—In patients receiving amiodarone because of life threatening ventricular arrhythmias after myocardial infarction, inducibility of ventricular fibrillation, but not of sustained monomorphic ventricular tachycardia, indicates a high risk of sudden death.
机译:目的—检查心脏程序性电刺激在预测胺碘酮治疗心肌梗死后室性快速性心律失常患者猝死中的价值。设计—连续患者;回顾性研究。设置-学术医院心脏病转诊中心。患者-心肌梗塞后晚期出现室性心动过速(n = 77)或室颤(n = 29)的患者106。干预-胺碘酮治疗至少一个月时进行了程序性电刺激。测量和主要结果-在80/106位患者中,诱发了室颤(n = 15)或持续性单形性室性心动过速(n = 65)。在平均随访50(SD 40)个月(1-144)之后,有11例患者突然死亡,其中2例使用了植入式心电除颤器。通过多变量分析,发现了两个猝死的预测因素:(1)胺碘酮治疗下室颤的可诱导性(P 0.001),和(2)左室射血分数<40%(P <0.05)。诱发心室纤颤的患者在一年,两年,三年和五年的存活率分别为70%,62%,62%和40%,对于患者,其存活率为98%,96%,94%,94%诱发持续性单形性室性心动过速。没有持续性心律失常的地方,五年生存率为100%。结论:在因心肌梗死后危及生命的室性心律失常而接受胺碘酮治疗的患者中,可诱发的室颤,而不是持续的单形性室性心动过速,提示发生猝死的风险较高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号